Author

Shahzad Khan

Wuhan University - Cited by 410 - pathology - pathophysiology - DM - inflammation

Biography

Shahzad Khan is currently affiliated to Wuhan University. Shahzad Khan is working as professor at Wuhan University School of Medicine. He is a researcher published 10 articles and done 5 projects related to field of medicine. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Kingdom of Saudi Arabia: A potential destination for medical tourism
S Khan, MS AlamJournal of Taibah University Medical Sciences 9 (4), 257-262, 2014201
91
2014
Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties
S Khan, D Zhang, Y Zhang, M Li, C WangMolecular and cellular endocrinology 428, 101-108, 2016201
52
2016
ER stress in adipocytes and insulin resistance: Mechanisms and significance
S Khan, CH WangMolecular medicine reports 10 (5), 2234-2240, 2014201
45
2014
PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion.
S Zhu, F Yao, WH Li, JN Wan, YM Zhang, Z Tang, S Khan, CH Wang, ...Asian Pacific journal of cancer prevention: APJCP 14 (10), 5687-5692, 2013201
28
2013
What is blockchain technology and its significance in the current healthcare system? A brief insight
SS Ahmad, S Khan, MA KamalCurrent pharmaceutical design 25 (12), 1402-1408, 2019201
23
2019
Alzheimer’s disease and autistic spectrum disorder: is there any association?
S A Khan, S A Khan, A R Narendra, G Mushtaq, S A Zahran, S Khan, ...CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016201
23
2016
Role of cardiac biomarkers in COVID-19: what recent investigations tell us?
S Khan, ST Rasool, SI AhmedCurrent Problems in Cardiology 46 (10), 100842, 2021202
18
2021
Current use of cardiac biomarkers in various heart conditions
S Khan, ST RasoolEndocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021202
18
2021
Can wogonin be used in controlling diabetic cardiomyopathy?
S Khan, MA KamalCurrent Pharmaceutical Design 25 (19), 2171-2177, 2019201
16
2019
The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review
SS Ahmad, S Khan, MA Kamal, U WasiCNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2019201
14
2019
Wogonin alleviates hyperglycemia through increased glucose entry into cells via AKT/GLUT4 pathway
S Khan, MA KamalCurrent Pharmaceutical Design 25 (23), 2602-2606, 2019201
13
2019
An efficient and secure revocation-enabled attribute-based access control for eHealth in smart society
S Khan, W Iqbal, A Waheed, G Mehmood, S Khan, M Zareei, RR BiswalSensors 22 (1), 336, 2022202
12
2022
Diabetic cardiomyopathy: From mechanism to management in a nutshell
S Khan, SS Ahmad, MA KamalEndocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021202
10
2021
Coagulopathy and plausible benefits of anticoagulation among COVID-19 patients
SI Ahmed, S KhanCurrent Problems in Cardiology 45 (9), 0648, 2020202
10
2020
Wogonin and alleviation of hyperglycemia via inhibition of DAG mediated PKC expression. a brief insight
S KhanProtein and peptide letters 28 (12), 135-1371, 2021202
6
2021
Cardiac biomarkers in stroke, Alzheimer’s disease, and other dementia. Are they of use? A brief overview of data from recent investigations
S Khan, MA KamalCNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2021202
4
2021

Referred From: https://scholar.google.com/citations?user=_xK3dcoAAAAJ&hl=en

Cited by
Citations 410
h-index 12
i10-index 15
Open Access Journals